Menu
Back to User profile » Dr Lu Yang
Papers published by Dr Lu Yang:
SKA3 Serves as a Biomarker for Poor Prognosis in Kidney Renal Papillary Cell Carcinoma
Feng D, Zhang F, Liu L, Xiong Q, Xu H, Wei W, Liu Z, Yang L
International Journal of General Medicine 2021, 14:8591-8602
Published Date: 23 November 2021
Combined Treatment of Radiotherapy and Immunotherapy for Urological Malignancies: Current Evidence and Clinical Considerations
Lei H, Shi M, Xu H, Bai S, Xiong X, Wei Q, Yang L
Cancer Management and Research 2021, 13:1719-1731
Published Date: 24 February 2021
Significance of tertiary Gleason pattern 5 in patients with Gleason score 7 after radical prostatectomy: a retrospective cohort study
Li J, Guo Y, Qiu S, He M, Jin K, Zheng X, Tu X, Liao X, Yang L, Wei Q
OncoTargets and Therapy 2019, 12:7157-7164
Published Date: 2 September 2019
Predictive value of preoperative neutrophil-to-lymphocyte ratio in non-metastatic papillary renal cell carcinoma patients after receiving curative surgery
Tu X, Wang F, Chang T, Zhang C, Zhang M, Liu Z, Qiu S, Yang L, Wei Q
Cancer Management and Research 2019, 11:7515-7524
Published Date: 7 August 2019
Immune-related adverse events following administration of anti-cytotoxic T-lymphocyte-associated protein-4 drugs: a comprehensive systematic review and meta-analysis
Xu H, Tan P, Zheng X, Huang Y, Lin T, Wei Q, Ai J, Yang L
Drug Design, Development and Therapy 2019, 13:2215-2234
Published Date: 4 July 2019
The accumulation of metabolic syndrome components is associated with higher risk of positive surgical margin among patients with localized prostate cancer after radical prostatectomy
Zheng X, Qiu S, Liao X, Han X, Jin K, Yang L, Wei Q
OncoTargets and Therapy 2019, 12:1613-1620
Published Date: 26 February 2019